TGA closes loophole on hyaluronic acid injections

The TGA has scheduled hyaluronic acid for intra-articular injection as a prescription medicine, closing a loophole that meant products used to treat arthritis were regulated as medical devices. In its latest round of re-scheduling decisions, the TGA’s Advisory Committee on Medicines Scheduling announced that the Schedule 4 listing for hyaluronic acid would be amended to add ...

Already a member?

Login to keep reading.

© 2021 the limbic